Data Security and Efficient Data Sharing in Pharma and Biotech Companies
When it comes to cybersecurity, pharmaceutical and biotechnology organizations are wearing the proverbial target on their backs. In fact, a study published by Deloitte called the sector the top target for cybercriminals. Cybercriminals exploit cybersecurity flaws to steal intellectual property from these organizations, often with severe consequences. Theft of intellectual property impacts the bottom line, with damage to brand trust, penalties from regulators, and wasted research investment. For companies managing patient data in clinical trials, the damage can be even more severe with individual patients suffering a loss of privacy and safety.
Complicating matters for these organizations is the need to collaborate. Pharmaceutical and biotechnology companies often partner with contract research organizations (CROs) and academic institutions when discovering and testing new drugs and therapies. This collaboration necessitates data sharing, which can open the door for cybercriminals.
With so much at stake, pharmaceutical and biotechnology companies continue seeking platforms that properly balance cybersecurity with the need for efficient flow of information between stakeholders.
In a blog on Technology Networks, Brian Stewart Sr. Director, Engineering at Thermo Fisher Scientific and Tess McCarthy, Sr. Manager, Cybersecurity Resilience & Culture at Thermo Fisher Scientific, discuss how cloud-based informatics platforms like Thermo Fisher™ Platform for Science™ software help pharmaceutical and biotechnology companies achieve this balance.
Cloud-based platforms like Platform for Science software provide an information pipeline that can grow and evolve with changing business needs. They allow businesses to add capabilities when needed, and provide flexible deployment options to meet the organization’s security requirements.
Click here to read the full Technology Networks blog and learn more about how Platform for Science software helps pharmaceutical and biotechnology companies balance cybersecurity with efficient data sharing.
Leave a Reply